Make more informed purchasing decisions with our new product availability and delivery estimate feature, now available on all product pages, in your cart, and during checkout.
Sign In
New to ƽ?
Register for an account to quickly and easily purchase products online and for one-click access to all educational content.
Please note that due to the high demand of this product, you may experience longer than usual wait times for order fulfillment. Contact us for real-time inventory and delivery estimates.
Request Pricing
Thank you for your interest in this product.
Please provide us with your contact information and your local representative
will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to ƽ Technologies Canada Inc. and its subsidiaries and affiliates (“ƽ”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Start your research confidently with a reliable supply of ethically sourced peripheral blood (PB) products from donors diagnosed with osteoarthritis (OA). OA is the most common form of arthritis caused by the progressive degeneration of protective cartilage that cushions bones, resulting in joint damage. Cells from donors with OA may be used to study the underlying molecular mechanisms involved in the disease pathology. Product options include fresh leukopaks, frozen mononuclear cells (MNCs or PBMCs), and plasma. Additional product options, including frozen leukopaks and other custom sizes, can also be requested through this form. We help you get the cells you need with personalized service and flexible delivery times.
Leukopaks are an enriched leukapheresis product consisting of a large number of single-donor MNCs, collected using the Spectra Optia® Apheresis System, with acid-citrate-dextrose solution A (ACDA) as the anticoagulant. Primary human MNCs are isolated from PB leukapheresis samples using density gradient separation or red blood cell lysis and cryopreserved in animal component-free CryoStor®CS10 medium (Catalog #07930). All PB products are obtained from donors diagnosed with OA, confirmed by the collection facility Medical Director, using Institutional Review Board (IRB)-approved consent forms and protocols. Additional documentation, donor disease and treatment information, and high-resolution HLA typing (Class I and Class II alleles) may be available upon request. Donor specifications (e.g. BMI category, age, ethnicity, etc.) can be requested in the comment box above, after selecting from the product options. Donors are screened for HIV-1, HIV-2, hepatitis B, and hepatitis C.
Certain products are only available in select territories. Please contact your local sales representative or Product & Scientific Support at techsupport@stemcell.com for further information.
This product is designed for use in the following research area(s) as part
of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we
offer to support each research area.
Diseased Human Peripheral Blood Products, Osteoarthritis
Please note that due to the high demand of this product, you may experience longer than usual wait times for order fulfillment. Contact us for real-time inventory and delivery estimates.
Quality Statement:
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED.